Academic Journal

The prognostic value of nuclear morphometric analysis in serous ovarian carcinoma

التفاصيل البيبلوغرافية
العنوان: The prognostic value of nuclear morphometric analysis in serous ovarian carcinoma
المؤلفون: Palmer, J. E., Sant Cassia, L. J., Irwin, C. J., Morris, A. G., Rollason, T. P.
المصدر: International Journal of Gynecologic Cancer ; volume 18, issue 4, page 692-701 ; ISSN 1048-891X 1525-1438
بيانات النشر: BMJ
سنة النشر: 2008
الوصف: The objective of this study was to determine whether nuclear morphometric data can predict survival, disease progression, and chemotherapeutic response in ovarian serous carcinoma. Nuclear morphometric parameters were determined from archival hematoxylin and eosin sections of 132 serous tumors. Clinicopathologic and morphometric parameters were evaluated as to their individual and independent prognostic value and prediction of chemotherapy response. Nuclear parameters were found to strongly correlate with extent of disease residuum, tumor grade, and FIGO stage. Univariate analysis revealed stage, grade, preoperative CA125, presence of ascites, extent of disease residuum, standard deviation of nuclear area (SDNA), nuclear perimeter (NP), SDNP, nuclear length (NL), nuclear breadth (NB), orthoferet, and equivalent diameter (ED) to be significant predictors of overall survival (OS) and disease-free survival (DFS). Grade, stage, extent of disease residuum, presence of ascites, SDNA, NP, NL, NB, and orthoferet were found to be significant predictors of chemotherapy response. Multivariate analysis revealed extent of disease residuum ( P ≤ 0.01) and ED ( P = 0.002) to be significant predictors for OS. FIGO stage ( P ≤ 0.01) and ED ( P = 0.039) were significant predictors of DFS. NL ( P = 0.041) and extent of residual disease ( P = 0.003) were the strongest predictors of chemotherapy response with correct classification rates of 68.8% and 70.3%, respectively. In all stages, nuclear morphometry was easy to perform and highly reproducible. Independent prognostic significance was achieved for OS and DFS analysis. Results also suggest that nuclear morphometry can provide significant information to predict chemotherapy response in platinum-treated serous ovarian cancer.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1136/ijgc-00009577-200807000-00013
الاتاحة: http://dx.doi.org/10.1136/ijgc-00009577-200807000-00013
https://syndication.highwire.org/content/doi/10.1136/ijgc-00009577-200807000-00013
رقم الانضمام: edsbas.75B44779
قاعدة البيانات: BASE
الوصف
DOI:10.1136/ijgc-00009577-200807000-00013